Skip to content
PubMed This is a summary of 66 peer-reviewed journal articles Updated
Oncology

Understanding Your UCD Diagnosis: You Are Not Alone

At a Glance

Unicentric Castleman Disease (UCD) is a rare, non-cancerous lymph node disorder limited to one area of the body. It is highly curable, and for most patients, surgically removing the enlarged lymph node is the only treatment needed for a full recovery.

Finding out you have a “tumor” or a “mass” is a terrifying experience that often leads to immediate fears of cancer. However, Unicentric Castleman Disease (UCD) is not cancer [1][2]. It is a rare, non-cancerous (benign) condition where a single lymph node or a group of nodes in one area of the body grows abnormally [1][3].

It is completely normal to feel overwhelmed or confused. Because UCD is so rare, many doctors may have never treated a case before, which can make the journey to a diagnosis feel lonely. Understanding exactly what UCD is—and what it isn’t—is the first step toward feeling back in control. Organizations like the Castleman Disease Collaborative Network (CDCN) exist to connect you with specialists and patient communities so you do not have to navigate this alone.

What is Unicentric Castleman Disease?

UCD is a lymphoproliferative disorder, which means your lymphocytes (a type of white blood cell) are multiplying more than they should, causing a lymph node to swell [1][2].

  • Unicentric means it is limited to one “center” or location in the body, such as the chest, neck, or abdomen [1].
  • Non-clonal means that, unlike cancer, the cells are not all identical copies of a single “bad” cell that is spreading and invading other tissues [1].

Why UCD is Not Cancer or MCD

It is important to distinguish UCD from two other conditions it is often compared to:

  • Lymphoma: While UCD can look like lymphoma on a scan, it is not a malignancy. It does not spread to other organs like cancer does [3].
  • Multicentric Castleman Disease (MCD): This is a different form of the disease that affects multiple areas of lymph nodes throughout the body and often causes severe “B-symptoms” like fever, night sweats, and weight loss [3][4]. People with UCD usually have no symptoms at all and feel perfectly healthy [3][2].

Understanding the Rarity

If you feel like you’ve been struck by lightning with this diagnosis, you are not far off. UCD is exceptionally rare.

  • Epidemiological data on Castleman disease subtypes remain limited and challenging to determine due to the rarity of the conditions [5][6].
  • Some research suggests that these conditions may be more common than once estimated, though they remain classified as rare diseases [7].
    Because it is so uncommon, it is highly recommended to seek care from a specialist or a center that has experience with Castleman disease.

A Highly Curable Condition

The most reassuring fact about UCD is that it is considered highly curable [8][9]. Because the disease is localized to one spot, the “gold standard” treatment is complete surgical resection—simply removing the affected lymph node or mass [10][11].

For the vast majority of patients:

  1. Surgery is often the only treatment needed: Removing the mass usually solves the problem entirely [9][10].
  2. Excellent Prognosis: Most people go on to live a normal, full life with no further issues [12][8].
  3. Low Recurrence: Once the node is removed, it is very rare for UCD to come back in that same spot [9][8].

While the word “disease” is heavy, UCD is a manageable condition with a very bright outlook. Your focus now will be on confirming the location of the mass and planning for its removal with your surgical team.

Navigate Your Care Journey:

Common questions in this guide

Is Unicentric Castleman Disease cancer?
No, Unicentric Castleman Disease is not cancer. It is a benign lymphoproliferative disorder where a lymph node grows abnormally, but unlike a malignancy, the cells do not spread to or invade other organs.
How is Unicentric Castleman Disease different from Multicentric Castleman Disease?
UCD is localized to a single lymph node or area and typically causes no symptoms. In contrast, Multicentric Castleman Disease (MCD) affects multiple lymph nodes throughout the body and often causes severe symptoms like fever, night sweats, and weight loss.
Is Unicentric Castleman Disease curable?
Yes, UCD is considered highly curable. The gold standard treatment is complete surgical removal of the affected lymph node. For most patients, this surgery is the only treatment required.
What are the subtypes of Unicentric Castleman Disease?
The main histological subtypes found on a pathology report are hyaline vascular, plasmacytic, and mixed. Your doctor will determine your exact subtype by examining the biopsied lymph node under a microscope.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Based on my scans, is this mass definitively localized to just one area?
  2. 2.Was my diagnosis based on a full excisional biopsy (removing the whole node) or just a small sample?
  3. 3.Which histological subtype was found in my pathology report: hyaline vascular, plasmacytic, or mixed?
  4. 4.Are there any reasons why surgery wouldn't be the first option for me?
  5. 5.How many patients with Castleman disease have you or this center treated?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (12)
  1. 1

    Clinical Presentation, Treatment, and Outcomes of 28 Patients With Castleman Disease: A Retrospective Analysis of an Italian Cohort.

    Cristinelli C, Merli M, Lucioni M, et al.

    EJHaem 2025; (6(6)):e70158 doi:10.1002/jha2.70158.

    PMID: 41210897
  2. 2

    Complete resection of unicentric Castleman disease in the superior mediastinum: A case report.

    Haro A, Kuramitsu E, Fukuyama Y

    International journal of surgery case reports 2016; (25()):44-7.

    PMID: 27318017
  3. 3

    Unicentric Castleman disease presenting as a longstanding axillary and chest wall mass: A case report.

    Zhou W, Liu X, Qiu A, et al.

    Clinical case reports 2023; (11(12)):e8258 doi:10.1002/ccr3.8258.

    PMID: 38054194
  4. 4

    Castleman's disease: Laparoscopic resection of unicentric disease in the hepatic hilum: A case report.

    Serpa Carmoma F, Cueva M, Serpa Carmoma F, et al.

    Annals of medicine and surgery (2012) 2021; (67()):102494 doi:10.1016/j.amsu.2021.102494.

    PMID: 34188910
  5. 5

    Historical and pathological overview of Castleman disease.

    Nishimura MF, Nishimura Y, Nishikori A, et al.

    Journal of clinical and experimental hematopathology : JCEH 2022; (62(2)):60-72 doi:10.3960/jslrt.21036.

    PMID: 35474035
  6. 6

    Multicentric Castleman disease: Where are we now?

    Wang HW, Pittaluga S, Jaffe ES

    Seminars in diagnostic pathology 2016; (33(5)):294-306.

    PMID: 27296355
  7. 7

    Epidemiological analysis of multicentric and unicentric Castleman disease and TAFRO syndrome in Japan.

    Masaki Y, Kawabata H, Fujimoto S, et al.

    Journal of clinical and experimental hematopathology : JCEH 2019; (59(4)):175-178 doi:10.3960/jslrt.19021.

    PMID: 31708515
  8. 8

    Retrospective analysis of primary extranodal unicentric Castleman disease: a systematic review.

    Shen J, Zeng Y, Liu Y, Xu N

    Frontiers in medicine 2026; (13()):1749931 doi:10.3389/fmed.2026.1749931.

    PMID: 41658580
  9. 9

    Unicentric Castleman Disease.

    Wong RSM

    Hematology/oncology clinics of North America 2018; (32(1)):65-73 doi:10.1016/j.hoc.2017.09.006.

    PMID: 29157620
  10. 10

    Pelvic unicentric Castleman's disease mimicking accessory spleen: A rare presentation of Castleman's disease, a case report and literature report.

    Emiru ZA, Getahun AM, Kassie YG, et al.

    International journal of surgery case reports 2025; (129()):111177 doi:10.1016/j.ijscr.2025.111177.

    PMID: 40106952
  11. 11

    Unicentric Castleman's Disease: Laparoscopic Approach of a Para-Duodenal Retroperitoneal Mass.

    Sawaya Z, Semaan DB, Nicolas G, et al.

    The American journal of case reports 2020; (21()):e918444 doi:10.12659/AJCR.918444.

    PMID: 32245939
  12. 12

    Clinical analysis for 12 patients with thoracic Castleman's disease.

    Shen C, Ouyang R, Liu G, Liu T

    Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences 2020; (45(11)):1336-1341 doi:10.11817/j.issn.1672-7347.2020.190203.

    PMID: 35753748

This page is for informational purposes only and does not replace professional medical advice. Always consult your healthcare provider or a specialist in Castleman disease about your specific diagnosis and treatment options.

Get notified when new evidence is published on Unicentric Castleman disease.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.